New drug IPH5301 targets tough cancers in first human trial
Disease control
Recruiting now
This early-phase study tests a new drug called IPH5301 in people with advanced solid tumors that have spread. The drug aims to block a protein (CD73) that helps cancers hide from the immune system. The study first finds a safe dose of IPH5301 alone, then tests it combined with ch…
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated May 01, 2026 16:00 UTC